JP Morgan Chase
MDCX icon

JP Morgan Chase’s Medicus Pharma MDCX Stock Holding History

JP Morgan Chase’s Portfolio MDCX Stock Details MDCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.02K Buy
513
+1
+0.2% +$14 ﹤0.01% 7340
2026
Q2 		$12.5K Buy
+512
New +$9.06K ﹤0.01% 6853

Other funds holding MDCX

Interchange Capital Partners
Interchange Capital Partners Pittsburgh, Pennsylvania $598M AUM 31.79% 1-Year Est. Return
Private Advisor Group
Private Advisor Group Morristown, New Jersey $29.9B AUM 19.22% 1-Year Est. Return
Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
Sterling Investment Advisors (Pennsylvania)
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $606M AUM 21.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
May Hill Capital
May Hill Capital Cohasset, Massachusetts $510M AUM 23.75% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $121B AUM 21.47% 1-Year Est. Return
Wilmington Savings Fund Society
Wilmington Savings Fund Society Wilmington, Delaware $4.39B AUM 17.99% 1-Year Est. Return
Smithfield Trust
Smithfield Trust Pittsburgh, Pennsylvania $2.51B AUM 13.63% 1-Year Est. Return

JP Morgan Chase's MDCX Position: Q3 2026 in Review

JP Morgan Chase increased its Medicus Pharma (MDCX) stake by 0.2% in Q3 2026, buying an estimated $14 and bringing the position to 513 shares worth $4.02K. The position accounts for ﹤0.01% of the portfolio, ranked #7340.

JP Morgan Chase first reported a position in MDCX in Q2 2026 and has held it in 2 quarters since. The position peaked at $12.5K in Q2 2026. 22 funds tracked by Wall St. Rank hold MDCX as of Q3 2026.

  • JP Morgan Chase held 513 shares of Medicus Pharma worth $4.02K as of Q3 2026.
  • JP Morgan Chase bought 1 Medicus Pharma share in Q3 2026, an estimated $14.
  • Medicus Pharma made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #7340 holding.
  • JP Morgan Chase first reported a position in Medicus Pharma in Q2 2026 and has held it in 2 quarters since.
  • JP Morgan Chase's Medicus Pharma position peaked at $12.5K in Q2 2026.
  • 22 funds tracked by Wall St. Rank held Medicus Pharma as of Q3 2026.

Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.